|
PROFILE
Biomedical Technology Solutions Holdings, Inc., located in Englewood, Colorado sells the Demolizer(R) II through its wholly owned subsidiary Biomedical Technology Solutions, Inc. BMTS' patented Demolizer(R) Technology converts infectious biomedical waste into non-infectious material. BMTS' products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the US.
| WHY INVEST |
 |
The Demolizer(R) II
The Demolizer(R) II is the GREEN alternative to biomedical waste disposal. The device is the only patented, portable, and self-contained system able to process both sharps and typical red bag biomedical waste onsite. The processed waste is rendered sterile and discarded as common trash eliminating up to 100% of the cost associated with its disposal. The Demolizer(R) II meets or exceeds all EPA and CDC guidelines and is approved or meets treatment requirements in 47 states after review by 78 governmental agencies. The device uses no chemicals or liquids, plugs into a normal outlet through a surge protector, and automatically records and prints state required documentation. The Demolizer(R) II provides a safer, more environmentally GREEN method for biomedical waste disposal.
The 4 S's
Savings, Safety, Simplicity and Security are the four main ways customers benefit from using the Demolizer(R) II system.
The system saves customers thousands by eliminating or dramatically reducing biomedical waste hauling costs and often pays for itself in one year or less.
Customers enjoy safer facilities because potentially hazardous biomedical waste is no longer handled multiple times or stored onsite, awaiting hauler pickup.
The process is simple to start and complete and needs no special chemical or electrical requirements. On completion, treated waste is thrown in common trash, and all state-required documentation is automatically generated.
The Demolizer(R) II is a proven, tested and approved solution to securely eliminate biomedical waste generator's cradle-to-grave liability without harming our environment.
Intellectual Property
Biomedical Technology Solutions technology is protected by their existing patent and patents pending worldwide on the system and the collectors. Biomedical Technology Solutions is constantly researching and developing improvements to their technology and continue to protect their intellectual property enhancements with additional filings.
The Market
There are more than one million low to medium volume generators of medical waste in the United States, and millions more worldwide. The Demolizer(R) II system is well-positioned to capture significant biomedical waste management market share in nursing homes, clinics, veterinary, public and military health care facilities.
The Management
Don G. Cox, Jr. serves as President, Chief Executive Officer, and Chairman of the Board of the Company. Don Cox is considered a leading expert in the retail industry for his proven ability to take a product from an idea to a concept and successful deployment both domestically and internationally. He has over twenty-five years experience in raising capital, contract negotiations, licensing, product design, operations, sales, and marketing. He has consulted for several companies in the areas of mergers, acquisitions, and exit strategies. He has a unique ability to build management teams with extensive expertise and very diverse backgrounds to create successful companies that are on the leading edge of their industries. Mr. Cox was once the largest national franchise operator of TCBY stores in the 1980s, chairing TCBY’s President’s Council, and an owner of a large area development agreement with Blockbuster. Most notably, he served as President, CEO and Chairman of the Board of Directors of Pretzelmaker, Inc. He took Pretzelmaker, a company on the verge of bankruptcy, to 220 stores in 40 states and 7 provinces in Canada and Asia in 18 short months. It became one of the fastest growing franchise chains in North America, outgrowing competitors nearly three to one and becoming one of Entrepreneurs Magazine’s top 200 franchises in 1996. As President and CEO, he was responsible for product development and store design, marketing and distribution, both domestic and international, and franchise business operations.
Current In-Store Program
BMTS announce on October 6th the in-store Demolizer® II Sharps Disposal Program and the placement of its first Demolizer(R) II in a Kroger pharmacy. This program is designed to establish a valuable, full service sharps life cycle solution to pharmacy syringe customers. With over 2,000 retail pharmacy outlets in the U.S., the placement of the first system in a Kroger pharmacy is an important benchmark for BMTS. BMTS believes this program will help to build national awareness of the growing public health and environmental problems associated with the improper or unsafe transportation and disposal of sharps waste generated at home. By establishing a safe, environmentally friendly and convenient in-store disposal method BMTS hopes to encourage the estimated 9 million people in the U.S. that administer 3 billion injections at home annually to take advantage of the in-store Demolizer(R) II sharps disposal program.
Future Plans
Developing countries have serious barriers to effective biomedical waste disposal. BMTS is working with global health leaders to combat those barriers by designing a system specifically for use in these developing areas.
The home health care (self-injector) market, although not rigorously regulated currently, is the source of billions of injections in the United States alone. Increasing pressure for regulatory oversight of the home health market will set the stage for market entry of the home Demolizer(R) unit currently in the initial design phase.
BMTS is also actively engaged in the development of a program designed to effectively and thoroughly recycle the Demolizer(R) end-product.
DISCLAIMER You are receiving this e-mail because you either opted into to our mailing list at smallcapvoice.com or at one of our Money Show exhibits. You may opt out at any time by clicking on the SafeUnsubscribe link at the bottom of this e-mail. Small Cap Voice SCV is an electronic publication, and is for informational purposes only. The stocks profiled by SCV are only company profiles and are not intended to be and should not be accepted by you as recommendations to buy or sell in these securities. These profiles are compiled from publicly available sources. Our sources include, but are not limited to, online research, company profiles, member suggestions, magazines, newspapers, analyst suggestions, broker recommendations, contact with the company, company rumors, press releases and other similar information sources. All profiles are based on information that is accessible by the public. Investing in stocks involves risk. SCV is not and does not hold itself out to be a registered broker or dealer or other licensed securities professional. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. For compensation and complete disclaimer click here. |
